This inventor holds 1 USPTO granted patent and 18 published patent applications and 1 EPO patent. Top assignees: Ercole Biotech, Inc., Santaris Pharma A/s, The University of North Carolina at Chapel Hill. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 44 
1 out of 1,326 
Years Active: 2010
Title: The Innovator Spotlight: Peter L Sazani - Revolutionizing Disease Treatment
Introduction: Peter L Sazani, a brilliant inventor based in Chapel Hill, NC (US), has made significant contributions to the field of medical science with his groundbreaking patent on soluble TNF receptors for the treatment of inflammatory diseases.
Latest Patents: Peter L Sazani holds one patent for his invention titled "Soluble TNF receptors and their use in treatment of disease." This patent focuses on the development of soluble secreted decoy receptors that bind to TNF and prevent its signaling to cells, offering a promising approach for combating inflammatory conditions.
Career Highlights: With a background in biotechnology, Peter L Sazani has worked with esteemed institutions such as Ercole Biotech, Inc. and the University of North Carolina at Chapel Hill. His expertise in molecular biology and pharmaceutical research has been instrumental in advancing innovative solutions for healthcare.
Collaborations: Throughout his career, Peter L Sazani has collaborated closely with accomplished professionals in the field, including Maria Graziewicz and Ryszard M Kole. Together, they have synergized their expertise to drive forward cutting-edge research in the realm of TNF antagonists and nucleic acids.
Conclusion: Peter L Sazani's pioneering work in the development of soluble TNF receptors stands as a testament to his ingenuity and dedication to improving patient outcomes in the realm of inflammatory diseases. His contributions have laid a solid foundation for future advancements in the field of biopharmaceuticals, setting a high standard for innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile